EM2P2

SaaS healthcare platform serving the needs of the medical cannabis market


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

em2p2:
fast facts

EM2P2 answers the call for connectivity and structure in the medical-cannabis market with CannaLnx®, a digital healthcare SaaS platform that connects patients, doctors, labs and dispensaries to improve data access and outcomes.

good news, bad news

When it comes to medical cannabis, there’s good news and bad news.


Failure to connect doctors, patients and dispensaries results in a lack of transparency, insufficient patient management and unmet health outcomes. 

With a HIPAA-compliant solution, the medical-cannabis community can close the information loop and clear the cloud of chaos. 

clearing the chaos with communication 

EM2P2 built CannaLnx alongside dozens of physicians and dispensaries.

CannaLnx completes the communication loop between doctors, patients, labs, growers and dispensaries in a secure HIPAA-compliant environment.

Our digital solution focuses on customer-centric, proactive healthcare and provides physicians with greater access and transparency to patient usage and impact data, resulting in improved health outcomes.

CannaLnx drives lead generation for physicians and dispensaries, by leveraging its targeted relationships with associations/unions and serving their members’ healthcare and wellness needs. These efforts dramatically expand the medical-cannabis patient pool.

As the industry grows, this highly interconnected industry platform can be seamlessly absorbed into traditional pharma solutions, linking the ever-expanding world of cannabis medicine.

CannaLnx key features 

CannaLnx provides an end-to-end solution for the medical-cannabis industry, acting as a secure communication solution for patients, doctors, dispensaries and others. 

Our HIPAA-compliant platform builds patient engagement. Powered by AI, CannaLnx can identify potential patients, help find qualified physicians, and locate quality dispensaries.

The innovative cloud-based SaaS solution standardizes, informs, streamlines and simplifies processes surrounding medical cannabis. CannaLnx creates connections and acts as an easy-to-use central repository for information vital to patients, doctors, dispensaries, growers and test labs.

As an all-in-one communication, transaction and reporting tool, CannaLnx supports the coordination of medical records, integrating with state patient registries, dispensary point of sale (POS) systems, and electronic medical records (EMR).

The platform also supports state-mandated transaction reporting requirements and serves as a reliable data hub for industry, regulators, researchers and medical cannabis pharma manufacturers.    

growing our brand

meet the em2p2 team


Gennaro Luce | CEO
30 years of expertise in marketing and marketing communications

Mike Paulus | COO
40 years in marketing and marketing communications
 

Howard Rothman | CIO
30 years in software development
 

Garnett Meador | President
30 years in legal and investments
 

David Speaker | Chief Communications Officer
40 years in legal, business writing, consulting, and strategic communications


Matthew Mar | Director of Marketing and Cannabis Science
20 years in cannabis
 

EM2P2’s six core executive team members bring decades of executive (C-suite), senior management, and professional experience in a range of businesses and industries to the enterprise.

Experienced in marketing, marketing communications, brand and sales management, legal, CRM, information technology, software development, public relations, strategic planning, management, and business development, the team is comprised of strong leaders who are strategic, tactical and creative thinkers with vision, drive and the ability to problem solve effectively as a team and individually.

Having worked together for over three years, the team also gains insight and expertise from EM2P2’s 11-member board of advisors—comprised of individuals from all sides of the industry, including educators, software designers, growers, pharmacists, ASCM, doctors, scientists, biochemists, and other experts on cannabinoids and emerging chemical knowledge.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.